Preparation and evaluation of mesalamine collagen in situ rectal gel: A novel therapeutic approach for treating ulcerative colitis

European Journal of Pharmaceutical Sciences

Volumn 48, Issue 1-2, 2013, Pages 104-110

  Ramadass, Satiesh Kumar ^a   Perumal, Sathiamurthi ^a   Jabaris, Sugin Lal ^b   Madhan, Balaraman ^a  

^a CENTRAL LEATHER RESEARCH INSTITUTE   (India)

^b SRI RAMACHANDRA UNIVERSITY   (India)

Author keywords

Collagen; Colonic mucosal damage; In situ gel; Mesalamine; Ulcerative colitis

Indexed keywords

COLLAGEN GEL; COLLAGEN TYPE 1; DEXTRAN SULFATE; MESALAZINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL REGENERATION; CHEMICAL MODIFICATION; COLON INJURY; CONTROLLED STUDY; DISEASE SEVERITY; DRUG EFFICACY; DRUG SCREENING; DRUG SYNTHESIS; FECES ANALYSIS; HISTOPATHOLOGY; IN VITRO STUDY; IN VIVO STUDY; MOUSE; NONHUMAN; PH; PRIORITY JOURNAL; RECTUM HEMORRHAGE; SCORING SYSTEM; SUSTAINED DRUG RELEASE; TEMPERATURE; ULCERATIVE COLITIS; WEIGHT CHANGE;

ADMINISTRATION, RECTAL; ANIMALS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; COLITIS, ULCERATIVE; COLLAGEN TYPE I; DEXTRAN SULFATE; DRUG COMPOUNDING; FEMALE; GELS; HYDROGEN-ION CONCENTRATION; MESALAMINE; MICE; MICE, INBRED BALB C; TEMPERATURE;

EID: 84869866637     PISSN: 09280987     EISSN: 18790720     Source Type: Journal    
DOI: 10.1016/j.ejps.2012.10.015     Document Type: Article

References (23)

1. N. Adhirajan, N. Shanmugasundaram, S. Shanmuganathan, and M. Babu Functionally modified gelatin microspheres impregnated collagen scaffold as novel wound dressing to attenuate the proteases and bacterial growth Eur. J. Pharm. Sci. 36 2009 235 245
2. P.G. Andres, and L.S. Friedman Epidemiology and the natural course of inflammatory bowel disease Gastroenterol. Clin. N. 28 1999 255 281
3. Ardizzone, S.; 2012. Ulcerative Colitis. Orphanet Encylcopedia 2003. < http://www.orpha.net/data/patho/GB/uk-UC.pdf > (accessed March 2012).
4. M.D. Baugh, M.J. Perry, A.P. Hollander, D.R. Davies, S.S. Cross, A.J. Lobo, C.J. Taylor, and G.S. Evans Matrix metalloproteinase levels are elevated in inflammatory bowel disease Gastroenterology 117 1999 814 822
5. G.W. Bos, J.J. Jacobs, J.W. Koten, S. Van Tomme, T. Veldhuis, C.F. van Nostrum, W. Den Otter, and W.E. Hennink In situ crosslinked biodegradable hydrogels loaded with IL-2 are effective tools for local IL-2 therapy Eur. J. Pharm. Sci. 21 2004 561 567
6. R.D. Cohen, D.M. Woseth, R.A. Thisted, and S.B. Hanauer A meta-analysis and overview of the literature on treatment options for left-sided ulcerative colitis and ulcerative proctitis Am. J. Gastroenterol. 95 2000 1263 1276
7. R. Groning, C. Cloer, M. Georgarakis, and R.S. Muller Compressed collagen sponges as gastroretentive dosage forms: in vitro and in vivo studies Eur. J. Pharm. Sci. 30 2007 1 6
8. P. Gionchetti, F. Rizzello, A. Venturi, M. Ferretti, C. Brignola, M. Miglioli, and M. Campieri Comparison of oral with rectal mesalazine in the treatment of ulcerative proctitis Dis. Colon Rectum 41 1998 93 97
9. W.I. Higuchi Analysis of data on the medicament release from ointments J. Pharm. Sci. 51 1962 802 804
10. A. Kornbluth, and D.B. Sachar Ulcerative colitis practice guidelines in adults: American College Of Gastroenterology, Practice Parameters Committee Am. J. Gastroenterol. 105 2010 501 523
11. C.H. Lee, A. Singla, and Y. Lee Biomedical applications of collagen Int. J. Pharm. 221 2001 1 22
12. E.S. Lee, Z. Gao, D. Kim, K. Park, I.C. Kwon, and Y.H. Bae Super pH-sensitive multifunctional polymeric micelle for tumor pH(e) specific TAT exposure and multidrug resistance J. Control. Release 129 2008 228 236
13. F. Loher, K. Schmall, P. Freytag, N. Landauer, R. Hallwachs, C. Bauer, B. Siegmund, F. Rieder, H.A. Lehr, M. Dauer, J.F. Kapp, S. Endres, and A. Eigler The specific type-4 phosphodiesterase inhibitor mesopram alleviates experimental colitis in mice J. Pharmacol. Exp. Ther. 305 2003 549 556
14. P. Marteau, C.S. Probert, S. Lindgren, M. Gassul, T.G. Tan, A. Dignass, R. Befrits, G. Midhagen, J. Rademaker, and M. Foldager Combined oral and enema treatment with pentasa (mesalazine) is superior to oral therapy alone in patients with extensive mild/moderate active ulcerative colitis: a randomised, double blind, placebo controlled study Gut 54 2005 960 965
15. J.K. Marshall, and E.J. Irvine Rectal aminosalicylate therapy for distal ulcerative colitis: a meta-analysis Aliment. Pharmacol. Therp. 9 1995 293 300
16. V. Natarajan, P. Saravanakumar, and B. Madhan Collagen adsorption on quercetin loaded polycaprolactone microspheres: approach for "stealth" implant Int. J. Biol. Macromol. 50 2012 1091 1094
17. R.K. Palsmeier, D.M. Radzik, and C.E. Lunte Investigation of the degradation mechanism of 5-aminosalicylic acid in aqueous solution Pharm. Res. 9 1992 933 938
18. J. Rosenblatt, B. Devereux, and D.G. Wallace Injectable collagen as a pH-sensitive hydrogel Biomaterials 15 1994 985 995
19. S. Tanaka, G. Avigad, E.F. Eikenberry, and B. Brodsky Isolation and partial characterization of collagen chains dimerized by sugar-derived cross-links J. Biol. Chem. 263 1988 17650 17657
20. H. Teles, T. Vermonden, D. Eggink, W.E. Hennink, and F.A. de Wolf Hydrogels of collagen-inspired telechelic triblock copolymers for the sustained release of proteins J. Control. Release 147 2010 298 303
21. S.P. Travis, E.F. Stange, M. Lemann, T. Oresland, W.A. Bemelman, Y. Chowers, J.F. Colombel, D. D'Haens, S. Ghosh, P. Marteau, W. Kruis, N.J. Mortensen, F. Penninckx, and M. Gassull European evidence-based consensus on the management of ulcerative colitis: current management J. Crohns Colitis 2 2008 24 62
22. Y.D. Wang, and J.W. Mao Expression of matrix metalloproteinase-1 and tumor necrosis factor-alpha in ulcerative colitis World J. Gastroenterol. 13 2007 5926 5932
23. Y.D. Wang, and P.Y. Yan Expression of matrix metalloproteinase-1 and tissue inhibitor of metalloproteinase-1 in ulcerative colitis World J. Gastroenterol. 12 2006 6050 6053